Tech Center 1600 • Art Units: 1651 1657
This examiner grants 50% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16975955 | COMPOSITIONS OF PARP14 MODULATORS AND/OR MUTANTS AND THERAPEUTIC USE THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 17931704 | COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE | Final Rejection | The Regents of the University of California |
| 18518183 | METHODS AND MATERIALS FOR USING BIOMARKERS WHICH PREDICT SUSCEPTIBILITY TO CLOSTRIDIUM DIFFICILE INFECTION | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 18484359 | METHODS OF INCREASING BIOMASS PRODUCTIVITY IN ALGAE CULTURES | Final Rejection | Arizona Board of Regents on Behalf of Arizona State University |
| 18000071 | RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR DUAL CELL AGGREGATES AND METHODS OF USE THEREOF | Non-Final OA | FUJIFILM Cellular Dynamics, Inc. |
| 18431638 | COMPOSITIONS AND METHODS OF ENHANCING ANTI-TUMOR RESPONSE USING HYBRID NEUTROPHILS | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17759864 | REGULATION OF POST-ISCHEMIC INFLAMMATORY RESPONSE: A FUNCTION OF TYROSINE PHOSPHATASE STEP | Non-Final OA | UNM Rainforest Innovations |
| 16973453 | Polyesterase II | Final Rejection | Henkel AG & Co. KGaA |
| 18323672 | PAN DOMAIN ACTIVATES UBIQUITINATION | Non-Final OA | UT-Battelle, LLC |
| 18029590 | New Granules for Animal Feed | Final Rejection | Novozymes A/S |
| 18735583 | PROBIOTIC (Bacillus subtilis) SUPPLEMENTATION FOR IMPROVEMENT OF BODY COMPOSITION IN FEMALE ATHLETES | Final Rejection | Deerland Enzymes, Inc. |
| 17812381 | REGENERATION OF RETINAL GANGLION CELLS | Final Rejection | SHANGHAITECH UNIVERSITY |
| 18606866 | INTESTINAL MICROBIOTA AND GVHD | Final Rejection | Memorial Sloan-Kettering Cancer Center |
| 17135415 | DETECTION OF LIPASE ACTIVITY IN HONEY BEES | Final Rejection | The United States of America, as Represented by the Secretary of Agriculture |
| 18416244 | ISOLATED DISCOGENIC CELLS, METHODS OF USING, AND METHODS OF PREPARING SAME FROM MAMMALIAN TISSUE | Final Rejection | DiscGenics, Inc. |
| 18267943 | Sialyltransferases for the Production of 6'-Sialyllactose | Non-Final OA | Chr. Hansen A/S |
| 18274539 | METHOD FOR PREDICTING OBESITY | Non-Final OA | Anicom Holdings, Inc. |
| 18267956 | METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MUSCULOSKELETAL AND/OR CONNECTIVE TISSUE DISEASE | Non-Final OA | Nightingale Health Oyj |
| 18263833 | PROTEIN-BASED MATERIAL FOR BIOCATALYSIS | Non-Final OA | Bondwell Technologies LP |
| 16862559 | SUSPENSION CULTURE OF HUMAN EMBRYONIC STEM CELLS | Final Rejection | Asterias Biotherapeutics, Inc. |
| 17292169 | METHOD FOR PRODUCING RARE SUGAR-CONTAINING COMPOSITION AND RARE SUGAR-CONTAINING COMPOSITION | Final Rejection | NATIONAL UNIVERSITY CORPORATION KAGAWA UNIVERSITY |
| 18037300 | METHOD AND DRUG FOR INCREASING NGF LEVEL | Non-Final OA | Talengen International Limited |
| 18317422 | MODULATION OF FUSOBACTERIUM VARIUM TO PREVENT BOVINE LIVER ABSCESSES AND IMPROVE CATTLE PERFORMANCE | Non-Final OA | Dr. Jacques Mathieu |
| 18031613 | Adenosine-Involved Fully Enzymatic Synthesis Method for NMN | Final Rejection | RUBYBERRIES BIOTECHNOLOGIES CO., LTD |
| 17049301 | MODIFIED MITOCHONDRIA AND USE THEREOF | Final Rejection | PAEAN BIOTECHNOLOGY INC. |
| 18029110 | REAGENT FOR DETECTING LIPOPROTEIN PARTICLE CONCENTRATION AND USING METHOD THEREOF | Final Rejection | MEDICAL SYSTEM BIOTECHNOLOGY CO., LTD. |
| 18115752 | COMPOSITION OF LACTIC BACTERIA FOR USE IN THE TREATMENT OF INFECTIONS DUE TO PROPIONIBACTERIUM ACNES AND IN PARTICULAR FOR ACNE | Final Rejection | Probiotical S.p.A. |
| 17999955 | MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION | Final Rejection | ALGENUITY HOLDINGS LTD |
| 17295949 | MODIFIED STRAINS OF CHLORELLA VULGARIS AND METHOD OF PRODUCTION | Final Rejection | ALGENUITY HOLDINGS LTD |
| 17647505 | MICRONIZED PLACENTAL TISSUE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Final Rejection | MiMedx Group, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy